<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-MedLine.d14">
    <sentence id="DDI-MedLine.d14.s0" text="[A pharmacological analysis of the effect of angiotensin on stimulated gastric secretion]&#xd;&#xa;Chronic experiments on dogs with gastric fistulas were carried out to study the influence of angiotensin 1 and angiotensin 2 on pentagastrin- and histamine-induced gastric acid secretion. ">
        <entity id="DDI-MedLine.d14.s0.e0" charOffset="45-55"
            type="drug_n" text="angiotensin"/>
        <entity id="DDI-MedLine.d14.s0.e1" charOffset="184-196"
            type="drug_n" text="angiotensin 1"/>
        <entity id="DDI-MedLine.d14.s0.e2" charOffset="202-214"
            type="drug_n" text="angiotensin 2"/>
        <entity id="DDI-MedLine.d14.s0.e3" charOffset="219-230"
            type="drug" text="pentagastrin"/>
        <entity id="DDI-MedLine.d14.s0.e4" charOffset="237-245"
            type="drug" text="histamine"/>
    </sentence>
    <sentence id="DDI-MedLine.d14.s1" text="It was established that both angiotensins inhibited gastric acid secretion stimulated by pentagastrin but not by histamine. ">
        <entity id="DDI-MedLine.d14.s1.e0" charOffset="89-100"
            type="drug" text="pentagastrin"/>
        <entity id="DDI-MedLine.d14.s1.e1" charOffset="113-121"
            type="drug" text="histamine"/>
    </sentence>
    <sentence id="DDI-MedLine.d14.s2" text="Comparative analysis of the effects of stimulation and inhibition of cholino- and adrenoreceptors on this inhibitory action of angiotensins suggested the mediation of angiotensin influence through the modulation of cholinergic reactions of parietal cells in the stomach.">
        <entity id="DDI-MedLine.d14.s2.e0" charOffset="127-138"
            type="drug_n" text="angiotensins"/>
        <entity id="DDI-MedLine.d14.s2.e1" charOffset="167-177"
            type="drug_n" text="angiotensin"/>
    </sentence>
</document>
